Stocks and Investing Stocks and Investing
Fri, February 16, 2024

Salveen Richter Maintained (ADPT) at Hold with Decreased Target to $5 on, Feb 16th, 2024


Published on 2024-10-28 09:02:42 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $11 to $5 on, Feb 16th, 2024.

Salveen has made no other calls on ADPT in the last 4 months.



There are 3 other peers that have a rating on ADPT. Out of the 3 peers that are also analyzing ADPT, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $10 on, Tuesday, October 24th, 2023


These are the ratings of the 2 analyists that currently disagree with Salveen


  • Rachel Vatnsdal of "JP Morgan" Maintained at Buy with Decreased Target to $8 on, Thursday, February 15th, 2024
  • David Westenberg of "Piper Sandler" Maintained at Buy with Decreased Target to $6 on, Monday, November 13th, 2023

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com